Zhejiang Hisun Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd. (China) holds 25 active US FDA Type II Drug Master Files and 65 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 3 FDA-registered manufacturing sites. 1 FDA enforcement record is linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Zhejiang Hisun Pharmaceutical Co., Ltd.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/zhejiang-hisun-pharmaceutical-co-ltd

Overview

Zhejiang Hisun Pharmaceutical Co., Ltd. is a leading pharmaceutical company in China dedicated to the research, development, manufacturing, and distribution of a wide array of therapeutic drugs. With a strong focus on innovation and quality, Hisun aims to improve health by providing effective and accessible medications worldwide.

Core services & business areas

API ProductionFormulation DevelopmentContract ManufacturingResearch and Development

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Zhejiang Hisun Pharmaceutical Co., Ltd. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Zhejiang Hisun Pharmaceutical Co., Ltd. holds 25 active (90 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • ORITAVANCIN DIPHOSPHATEActive2026-08-31
  • APALUTAMIDEActive2025-12-30
  • RESMETIROMActive2025-12-26
  • FINERENONEActive2025-09-25
  • LETERMOVIRActive2025-07-30
  • TICAGRELORActive2014-12-25
  • LINEZOLIDActive2014-09-05
  • MICAFUNGIN SODIUM USPActive2013-09-25
  • DOXORUBICIN HYDROCHLORIDE USP (FERMENTATION)Active2013-09-09
  • DONEPEZIL HYDROCHLORIDE USPActive2012-12-27
  • BLEOMYCIN SULFATE USP (PROCESS II)Active2012-09-21
  • TIGECYCLINE USPActive2012-09-04
  • MINOCYCLINE HYDROCHLORIDE USPActive2012-07-20
  • MITOMYCIN USP (ALTERNATIVE PROCESS)Active2011-12-30
  • IVERMECTIN USPActive2008-05-08
  • DACTINOMYCIN USPActive2007-06-20
  • ACARBOSE USPActive2005-12-14
  • ADENOSINE USPActive2004-04-12
  • FLUDARABINE PHOSPHATE USPActive2003-08-27
  • MESNA USPActive2002-11-15
  • CLADRIBINE USPActive2002-10-22
  • CYTARABINE USPActive2002-04-28
  • CYCLOPHOSPHAMIDE USPActive2000-12-01
  • DOXORUBICIN HYDROCHLORIDE USPActive1998-09-01
  • DAUNORUBICIN HYDROCHLORIDE USPActive1998-09-01
  • PALBOCICLIBInactive2018-11-30
  • APIXABANInactive2018-10-30
  • ROMIDEPSINInactive2018-09-29
  • DASATINIBInactive2014-06-19
  • ARIPIPRAZOLE USPInactive2014-06-11
  • DECITABINEInactive2014-03-12
  • ROSUVASTATIN CALCIUMInactive2013-12-26
  • IRINOTECAN HYDROCHLORIDE USPInactive2013-12-19
  • OXALIPLATIN USPInactive2013-12-13
  • PIOGLITAZONE HYDROCHLORIDE USPInactive2013-12-02
  • PRAVASTATIN SODIUM USP (PROCESS II)Inactive2013-10-21
  • DOCETAXEL TRIHYDRATE USPInactive2013-09-27
  • BORTEZOMIBInactive2013-09-12
  • GEFITINIBInactive2013-07-26
  • OLANZAPINE USPInactive2013-07-09
  • CAPECITABINE USPInactive2013-03-29
  • MEROPENEM STERILEInactive2013-01-31
  • IMATINIB MESYLATEInactive2012-12-30
  • VALSARTAN USPInactive2012-12-19
  • QUETIAPINE FUMARATEInactive2012-12-18
  • PITAVASTATIN CALCIUMInactive2012-12-16
  • DEMECLOCYCLINE HYDROCHLORIDE USPInactive2012-06-14
  • SIMVASTATIN (BHA ADDED) USPInactive2012-05-23
  • FLUVASTATIN SODIUM USPInactive2012-04-28
  • ANASTROZOLE USPInactive2012-03-31

Showing the 50 most relevant of 90 Drug Master Files (active first). The full list is in the FDA DMF list.

Registered manufacturing sites (3)

Physical sites registered with the US FDA and resolved to Zhejiang Hisun Pharmaceutical Co., Ltd., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

1 FDA enforcement record linked to this company.

  • warning_letter2016-01-04

    FDA Warning Letter (drug product)

For suppliers

Is this Zhejiang Hisun Pharmaceutical Co., Ltd.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.